
Sugamide PM 2mg/500mg/15mg Tablet SR
Marketer
Intra Life
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugamide PM 2mg/500mg/15mg Tablet SR
Diabetol Plus 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. In adults with type 2 diabetes, this regimen complements diet and exercise to enhance glycemic control. It facilitates efficient insulin use, reducing blood sugar. Follow your physician's prescribed dosage and regimen for Diabetol Plus. Take it with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then omit the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; monitor blood sugar levels carefully. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting, inform your doctor about kidney, liver, or heart conditions. Pregnant or breastfeeding individuals should consult their doctor. Kidney function will be assessed prior to treatment. Limit alcohol consumption to mitigate potential side effects.
Uses of Sugamide PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugamide PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sugamide PM 2mg/500mg/15mg Extended-Release Tablet with food.
Common Side effects of Sugamide PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugamide PM 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sugamide PM 2mg/500mg/15mg Extended-Release Tablets with a meal.
How Sugamide PM 2mg/500mg/15mg Tablet SR works:
Sugamide PM 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple-combination therapy improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugamide PM 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Sugamide PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugamide PM 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Sugamide PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. The use of Sugamide PM 2mg/500mg/15mg SR tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sugamide PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sugamide PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sugamide PM 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Sugamide PM 2mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugamide PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
